查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
疼痛管理设备的全球市场：按类型、按应用、按采购模式、按最终用户、按地区 - 预测到 2029 年
市场调查报告书
商品编码
1575716

疼痛管理设备的全球市场：按类型、按应用、按采购模式、按最终用户、按地区 - 预测到 2029 年

Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 298 Pages | 订单完成后即时交付

价格

全球疼痛管理设备市场规模预计将从 2024 年的 37.686 亿美元增加到 2029 年的 58.358 亿美元，预测期内复合年增长率为 9.1%。

全球老年人口的快速成长和慢性疼痛患者的大幅增加预计将推动疼痛管理设备市场的需求。由于患者意识的提高，疼痛管理设备的使用逐渐增加，预计也将支持市场成长。预计疼痛管理设备技术的进步、新产品的推出、有利的报销和政府政策、医疗保健基础设施的投资以及提高疼痛管理设备的可用性和可负担性的倡议将推动市场成长。

调查范围
调查年份 2024-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元）
部分 按类型、用途、购买形式、最终用户、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲（GCC 国家、RoMEA）

在疼痛管理设备市场中，神经刺激设备疼痛管理设备部分预计在预测期内将以显着的速度成长。由于技术进步提高了慢性疼痛治疗​​的功效、微创性、功能性和患者舒适度，疼痛管理市场对神经刺激设备的需求不断增加。

疼痛管理设备市场按应用细分为神经病变疼痛、肌肉骨骼疼痛、癌症疼痛、脸部/偏头痛和其他应用。在预测期内，神经病变领域将占据最大份额，复合年增长率也很高。神经病变疼痛在世界范围内的高盛行率、临床证据支持疼痛管理装置在治疗神经病变疼痛方面的高效性、新型装置的开发以及许多与老龄化相关的疾病的相关影响使得神经病变疼痛的发病率神经病变神经病变。

该报告研究了全球疼痛管理设备市场，包括按类型、应用程式、购买模式、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 技术分析
  • 产业动态
  • 供应链分析
  • 贸易分析
  • 波特五力分析
  • 监管状况
  • 专利分析
  • 价格分析
  • 2024-2025年重大会议和活动
  • 主要相关人员和采购标准
  • 生态系分析
  • 案例研究分析
  • 报销分析
  • 疼痛管理设备市场未满足的需求
  • 价值链分析
  • 最终用户对疼痛管理市场的期望
  • 人工智慧/产生人工智慧对疼痛管理设备市场的影响
  • 影响客户业务的趋势和颠覆
  • 投资金筹措场景

第六章疼痛管理设备市场（按类型）

  • 介绍
  • 神经刺激装置
  • 点滴帮浦
  • 消融装置

第七章疼痛管理设备市场（按应用）

  • 介绍
  • 神经病变疼痛
  • 肌肉骨骼疼痛
  • 癌症痛
  • 脸部疼痛和偏头痛
  • 其他的

第八章疼痛管理设备市场（按购买类型）

  • 介绍
  • 基于处方笺
  • OTC

第九章疼痛管理设备市场（按最终用户）

  • 介绍
  • 医院/诊所
  • 物理治疗中心
  • 居家照护
  • 其他的

第10章疼痛管理设备市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十一章竞争格局

  • 介绍
  • 主要参与企业的策略/秘密，2021-2024
  • 2021-2023 年收益分析
  • 2023 年市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 品牌/产品比较
  • 研发评估
  • 企业价值评估及财务指标
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • MEDTRONIC
    • BOSTON SCIENTIFIC CORPORATION
    • ABBOTT LABORATORIES
    • NEVRO CORP.
    • BECTON, DICKINSON AND COMPANY
    • STRYKER
    • B. BRAUN SE
    • BAXTER
    • OMRON CORPORATION
    • AVANOS MEDICAL, INC.
    • TELEFLEX INCORPORATED
    • ICU MEDICAL, INC.
    • NIPRO
    • MOOG INC.
    • ATRICURE, INC.
    • MICREL MEDICAL DEVICES SA
    • ZYNEX, INC.
    • ENOVIS CORPORATION
  • 其他公司
    • EPIC MEDICAL
    • SOTERIX MEDICAL INC.
    • GIMER MEDICAL
    • NEURONANO AB
    • ICECURE MEDICAL
    • BIOWAVE
    • THERANICA BIO-ELECTRONICS LTD.

第十三章附录

Product Code: MD 4371

The global pain management devices market is projected to reach USD 5,835.8 million by 2029 from USD 3,768.6 million in 2024, at a CAGR of 9.1% during the forecast period. The rapid growth in the geriatric population globally and the significant rise in the patients with chronic pain conditions are expected to boost the demand for pain management devices market. Moreover, gradual rise in utilization of pain management devices due to improved awareness among patients is likely to support the market growth. Advancements in pain management devices technology, new product launches, favourable reimbursement and government policies, investments in healthcare infrastructure, and initiatives to enhance the accessibility and affordability of pain management devices is anticipated to fuel the market growth.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD)
SegmentsType, Application, Mode Of Purchase, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, and MEA (GCC Countries, RoMEA)

"The Neurostimulation devices segment of pain management devices market to grow with the highest CAGR during the forecast period."

Based on the pain management devices market, the Neurostimulation devices pain management devices segment is anticipated to grow at significant rate during forecast period. The demand for neurostimulation devices in the pain management market is increasing due to their effectiveness in treating chronic pain, their minimally invasive nature, and advancements in technology that enhance their functionality and patient comfort .These factors are fostering the growth of neurostimulation devices at higher pace.

"The neuropathic pain segment of application segment to capture the largest market share of pain management devices market."

Based on application, the pain management devices market is segmented into neuropathic pain, musculoskeletal pain, cancer pain, facial & migraine , and other applications. The neuropathic segment is to capture the largest share and the higher CAGR during the forecast period. Owing to high prevalence of neuropathic pain across the globe, presence of substantial clinical evidence in the favor of high efficacy of pain management devices in neuropathic pain treatment, development of novel devices, the rising geriatric population is at high risk of neuropathic pain due to the increased incidence of neuropathic pain associated with many age-related diseases, side effects of drugs used to treat neuropathic pain, and availability of favorable reimbursement are boosting the adoption of pain management devices for neuropathic pain conditions.

"North America accounted for the largest share of the pain management devices market by region."

The global pain management devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for pain management devices, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The largest share of North America is attributed to the high disease burden of chronic disease and pain conditions contributing to a larger pool of patients requiring pain management devices products. The presence of numerous potential market giants and favorable reimbursement policy in the region is likely to promote the growth of pain management devices market in North America.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-60%, Tier 2-30%, and Tier 3- 10%
  • By Designation: Directors-50%, Managers-30% and Others-20%
  • By Region: North America-45%, Europe-15%, Asia Pacific-25% and RoW-15%

The major players operating in the pain management devices market market are Medtronic (Ireland), Boston Scientific Corporation(US), Abbott Laboratories (US), Stryker (US), Nevro Corp. (US), Becton, Dickinson and Company (US), Baxter (US), B. Braun SE (Germany), Omron Corporation (Japan), Avanos Medical, Inc. (US), Teleflex Incorporated (US),ICU Medical, Inc. (US), Nipro (Japan), Moog Inc. (US), Atricure, Inc. (US), Micrel Medical Devices SA (Greece), Zynex, Inc.(US), and Enovis Corporation (US).

Research Coverage

This report studies the pain management devices market based on type, application, mode of purchase, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Analysis of Key divers (increasing prevalence of chronic pain conditions, rising demand of pain management devices in home care settings, , new product launches & approvals, favourable reimbursement scenario and government initiatives), restraints (high procedural cost, product recalls), Opportunities (emerging markets, expanding base of pain management clinics/centers ) , Challenge (stringent regulatory requirement, use of pain medication as first-line treatment for pain management)
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the pain management devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the pain management devices market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from industry experts
      • 2.1.2.3 Breakdown of primary interviews
      • 2.1.2.4 Supply-side and demand-side participants
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PAIN MANAGEMENT DEVICES MARKET
  • 4.2 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AND COUNTRY
  • 4.3 PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Surge in demand for at-home pain management devices
      • 5.2.1.2 Increase in surgical procedures
      • 5.2.1.3 Prevalence of chronic pain conditions
      • 5.2.1.4 Favorable reimbursement policies for spinal cord stimulation devices
      • 5.2.1.5 Growing launches and regulatory approvals for advanced pain management devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Rise in product recalls
      • 5.2.2.2 High procedural and purchase cost of pain management devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Untapped growth potential in emerging economies
      • 5.2.3.2 Expansion of pain management clinics
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Use of pain medication as first line of treatment
      • 5.2.4.2 Stringent regulatory norms for FDA approval
  • 5.3 TECHNOLOGY ANALYSIS
    • 5.3.1 KEY TECHNOLOGIES
      • 5.3.1.1 Wearable devices
      • 5.3.1.2 Implantable pumps
    • 5.3.2 COMPLEMENTARY TECHNOLOGIES
      • 5.3.2.1 Virtual reality
      • 5.3.2.2 Digital therapeutics
    • 5.3.3 ADJACENT TECHNOLOGIES
      • 5.3.3.1 Robotics
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 ELECTROTHERAPY DEVICES
    • 5.4.2 RECHARGEABLE SPINAL CORD STIMULATORS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 TRADE ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT FROM NEW ENTRANTS
    • 5.7.2 THREAT FROM SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY LANDSCAPE
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
      • 5.8.1.2 Canada
    • 5.8.2 EUROPE
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 Japan
      • 5.8.3.2 China
      • 5.8.3.3 India
    • 5.8.4 LATIN AMERICA
      • 5.8.4.1 Brazil
      • 5.8.4.2 Mexico
    • 5.8.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 PATENT ANALYSIS
  • 5.10 PRICING ANALYSIS
  • 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 BUYING CRITERIA
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 REIMBURSEMENT ANALYSIS
  • 5.16 UNMET NEEDS IN PAIN MANAGEMENT DEVICES MARKET
  • 5.17 VALUE CHAIN ANALYSIS
  • 5.18 END USER EXPECTATIONS IN PAIN MANAGEMENT DEVICES MARKET
  • 5.19 IMPACT OF AI/GEN AI IN PAIN MANAGEMENT DEVICES MARKET
  • 5.20 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.21 INVESTMENT AND FUNDING SCENARIO

6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 NEUROSTIMULATION DEVICES
    • 6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
      • 6.2.1.1 Surge in demand for non-invasive therapy to drive market
    • 6.2.2 SPINAL CORD STIMULATORS
      • 6.2.2.1 Extensive use of SCS for pain treatment to drive market
    • 6.2.3 OTHERS
  • 6.3 INFUSION PUMPS
    • 6.3.1 INTRATHECAL INFUSION PUMPS
      • 6.3.1.1 Increasing incidences of chronic pain to drive market
    • 6.3.2 EXTERNAL INFUSION PUMPS
      • 6.3.2.1 Availability of reimbursement to drive market
  • 6.4 ABLATION DEVICES
    • 6.4.1 RADIOFREQUENCY ABLATION DEVICES
      • 6.4.1.1 Low cost of RF ablation procedures to drive market
    • 6.4.2 CRYOABLATION ABLATION DEVICES
      • 6.4.2.1 Successful clinical trials to drive market
    • 6.4.3 ULTRASOUND ABLATION DEVICES
      • 6.4.3.1 Efficacy in targeted pain management to drive market
    • 6.4.4 OTHERS

7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 NEUROPATHIC PAIN
    • 7.2.1 HIGH EFFICACY OF PAIN MANAGEMENT DEVICES IN NEUROPATHIC PAIN TREATMENT TO DRIVE MARKET
  • 7.3 MUSCULOSKELETAL PAIN
    • 7.3.1 SURGE IN AGING POPULATION TO DRIVE MARKET
  • 7.4 CANCER PAIN
    • 7.4.1 PREVALENCE OF CANCER TO DRIVE MARKET
  • 7.5 FACIAL PAIN & MIGRAINE
    • 7.5.1 INTRODUCTION OF NOVEL PAIN MANAGEMENT DEVICES TO DRIVE MARKET
  • 7.6 OTHER APPLICATIONS

8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

  • 8.1 INTRODUCTION
  • 8.2 PRESCRIPTION-BASED
    • 8.2.1 INCREASING INCIDENCES OF MEDICAL DISORDERS TO DRIVE MARKET
  • 8.3 OVER-THE-COUNTER
    • 8.3.1 ACCESSIBILITY OF OTC PAIN MANAGEMENT DEVICES TO DRIVE MARKET

9 PAIN MANAGEMENT DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS & CLINICS
  • 9.3 PHYSIOTHERAPY CENTERS
    • 9.3.1 RISE OF SPORTS INJURIES AND MUSCULOSKELETAL DISORDERS TO DRIVE MARKET
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 HIGH COST OF HOSPITALIZATION TO DRIVE MARKET
  • 9.5 OTHER END USERS

10 PAIN MANAGEMENT DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 Favorable reimbursement policies to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing incidences of chronic pain to drive market
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK
    • 10.3.2 GERMANY
      • 10.3.2.1 Robust healthcare infrastructure to drive market
    • 10.3.3 FRANCE
      • 10.3.3.1 Government initiatives for lowering healthcare costs to drive market
    • 10.3.4 UK
      • 10.3.4.1 Shift toward home care settings to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Growing healthcare investments to drive market
    • 10.3.6 SPAIN
      • 10.3.6.1 Surge in new cancer cases to drive market
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 MACROECONOMIC OUTLOOK
    • 10.4.2 JAPAN
      • 10.4.2.1 Large geriatric population to drive market
    • 10.4.3 CHINA
      • 10.4.3.1 Growing investments in healthcare infrastructure development to drive market
    • 10.4.4 INDIA
      • 10.4.4.1 High prevalence of lifestyle diseases to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Initiatives promoting development of novel pain management devices to drive market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Growing demand for effective treatment options to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 MACROECONOMIC OUTLOOK
    • 10.5.2 BRAZIL
      • 10.5.2.1 Private and government sector awareness programs to drive market
    • 10.5.3 MEXICO
      • 10.5.3.1 Domestic health coverage schemes to drive market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 High healthcare spending capacity to drive market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
  • 11.3 REVENUE ANALYSIS, 2021-2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Type footprint
      • 11.5.5.3 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING
  • 11.7 BRAND/PRODUCT COMPARISON
  • 11.8 R&D ASSESSMENT
  • 11.9 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT APPROVALS/LAUNCHES
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS
    • 11.10.4 OTHERS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 MEDTRONIC
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Product approvals/launches
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 BOSTON SCIENTIFIC CORPORATION
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 ABBOTT LABORATORIES
      • 12.1.3.1 Business overview
      • 12.1.3.2 Product offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product approvals/launches
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 NEVRO CORP.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Product approvals/launches
        • 12.1.4.3.2 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Key strengths
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 BECTON, DICKINSON AND COMPANY
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Others
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 STRYKER
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Expansions
    • 12.1.7 B. BRAUN SE
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
        • 12.1.7.3.2 Others
    • 12.1.8 BAXTER
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
    • 12.1.9 OMRON CORPORATION
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 AVANOS MEDICAL, INC.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
        • 12.1.10.2.1 Deals
    • 12.1.11 TELEFLEX INCORPORATED
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 ICU MEDICAL, INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Deals
    • 12.1.13 NIPRO
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Expansions
    • 12.1.14 MOOG INC.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 ATRICURE, INC.
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Product approvals/launches
    • 12.1.16 MICREL MEDICAL DEVICES SA
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
    • 12.1.17 ZYNEX, INC.
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products offered
    • 12.1.18 ENOVIS CORPORATION
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 EPIC MEDICAL
    • 12.2.2 SOTERIX MEDICAL INC.
    • 12.2.3 GIMER MEDICAL
    • 12.2.4 NEURONANO AB
    • 12.2.5 ICECURE MEDICAL
    • 12.2.6 BIOWAVE
    • 12.2.7 THERANICA BIO-ELECTRONICS LTD.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD EXCHANGE RATES
  • TABLE 2 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 3 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 4 IMPACT OF PORTER'S FIVE FORCES
  • TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES
  • TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 7 US: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 8 CANADA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 9 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 11 BRAZIL: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 12 MEXICO: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 PATENT ANALYSIS, 2023-2024
  • TABLE 19 INDICATIVE PRICING OF PAIN MANAGEMENT DEVICES, BY REGION, 2023 (USD)
  • TABLE 20 KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE (%)
  • TABLE 22 KEY BUYING CRITERIA, BY TYPE
  • TABLE 23 ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 24 CELIAC PLEXUS CRYO-NEUROLYSIS FOR PALLIATIVE PAIN MANAGEMENT IN PANCREATIC CANCER
  • TABLE 25 GET READY REMOTE PATIENT MANAGEMENT SOLUTION FOR TIMELY CHRONIC PAIN TREATMENT OF
  • TABLE 26 MEDICARE CODING AND NATIONAL PAYMENT RATES FOR RADIOFREQUENCY ABLATION (SACROILIAC JOINT) PROCEDURES
  • TABLE 27 MEDICARE CODING AND NATIONAL PHYSICIAN PAYMENT RATES FOR SPINAL CORD STIMULATION PROCEDURES
  • TABLE 28 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 30 NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 OTHER NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 35 INFUSION PUMPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 INTRATHECAL INFUSION PUMPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 EXTERNAL INFUSION PUMPS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 39 ABLATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 RF ABLATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 CRYOABLATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 ULTRASOUND DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 OTHER ABLATION DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 45 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 CANCER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 OTHER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 51 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 54 PAIN MANAGEMENT DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 PAIN MANAGEMENT DEVICES MARKET FOR PHYSIOTHERAPY CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 PAIN MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 PAIN MANAGEMENT DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 PAIN MANAGEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 NORTH AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 67 NORTH AMERICA: KEY MACRO INDICATORS
  • TABLE 68 US: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 US: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 US: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 US: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 72 US: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 73 US: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 74 US: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 75 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 CANADA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 CANADA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 CANADA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 80 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 81 CANADA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 82 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 EUROPE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 EUROPE: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 EUROPE: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 88 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 90 EUROPE: KEY MACRO INDICATORS
  • TABLE 91 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 GERMANY: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 GERMANY: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 GERMANY: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 96 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 97 GERMANY: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 98 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 FRANCE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 FRANCE: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 FRANCE: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 103 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 104 FRANCE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 105 UK: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 UK: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 UK: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 UK: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 UK: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 110 UK: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 111 UK: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 112 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 ITALY: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 ITALY: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 ITALY: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 117 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 118 ITALY: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 119 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 SPAIN: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 SPAIN: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 SPAIN: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 124 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 125 SPAIN: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 REST OF EUROPE: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 131 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 132 REST OF EUROPE: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: KEY MACRO INDICATORS
  • TABLE 142 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 JAPAN: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 JAPAN: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 JAPAN: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 147 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 148 JAPAN: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 149 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 CHINA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 CHINA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 CHINA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 154 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 155 CHINA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 156 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 INDIA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 INDIA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 INDIA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 161 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 162 INDIA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 163 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 AUSTRALIA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 AUSTRALIA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 AUSTRALIA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 168 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 169 AUSTRALIA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 170 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 SOUTH KOREA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 SOUTH KOREA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 SOUTH KOREA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 175 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 176 SOUTH KOREA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 184 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 190 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: KEY MACRO INDICATORS
  • TABLE 193 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 194 BRAZIL: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 BRAZIL: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 BRAZIL: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 198 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 199 BRAZIL: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 200 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 MEXICO: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 MEXICO: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 MEXICO: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 205 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 206 MEXICO: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: KEY MACRO INDICATORS
  • TABLE 223 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 GCC COUNTRIES NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 230 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 REST OF MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 REST OF MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 235 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 237 PAIN MANAGEMENT DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 238 TYPE FOOTPRINT
  • TABLE 239 REGION FOOTPRINT
  • TABLE 240 LIST OF START-UPS/SMES
  • TABLE 241 COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 242 PAIN MANAGEMENT DEVICES MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 243 PAIN MANAGEMENT DEVICES MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 244 PAIN MANAGEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 245 PAIN MANAGEMENT DEVICES MARKET: OTHERS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 246 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 247 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 248 MEDTRONIC: PRODUCT APPROVALS/LAUNCHES
  • TABLE 249 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 250 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 251 BOSTON SCIENTIFIC CORPORATION: DEALS
  • TABLE 252 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 253 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • TABLE 254 ABBOTT LABORATORIES: PRODUCT LUNCHES/APPROVALS
  • TABLE 255 NEVRO CORP.: COMPANY OVERVIEW
  • TABLE 256 NEVRO CORP: PRODUCTS OFFERED
  • TABLE 257 NEVRO CORP.: PRODUCT APPROVALS/LAUNCHES
  • TABLE 258 NEVRO CORP.: DEALS, JANUARY 2021- SEPTEMBER 2024
  • TABLE 259 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
  • TABLE 260 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
  • TABLE 261 BECTON, DICKINSON AND COMPANY: OTHERS
  • TABLE 262 STRYKER: COMPANY OVERVIEW
  • TABLE 263 STRYKER: PRODUCTS OFFERED
  • TABLE 264 STRYKER: EXPANSIONS
  • TABLE 265 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 266 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 267 B. BRAUN SE: DEALS
  • TABLE 268 B. BRAUN SE: OTHERS
  • TABLE 269 BAXTER: COMPANY OVERVIEW
  • TABLE 270 BAXTER: PRODUCTS OFFERED
  • TABLE 271 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 272 OMRON CORPORATION: PRODUCTS OFFERED
  • TABLE 273 AVANOS MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 274 AVANOS MEDICAL, INC.: PRODUCTS OFFERED
  • TABLE 275 AVANOS MEDICAL, INC.: DEALS
  • TABLE 276 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 277 TELEFLEX INCORPORATED: PRODUCTS OFFERED
  • TABLE 278 ICU MEDICAL, INC.:COMPANY OVERVIEW
  • TABLE 279 ICU MEDICAL: PRODUCTS OFFERED
  • TABLE 280 ICU MEDICAL: DEALS
  • TABLE 281 NIPRO: COMPANY OVERVIEW
  • TABLE 282 NIPRO: PRODUCTS OFFERED
  • TABLE 283 NIPRO: EXPANSIONS
  • TABLE 284 MOOG INC.: COMPANY OVERVIEW
  • TABLE 285 MOOG INC.: PRODUCTS OFFERED
  • TABLE 286 ATRICURE, INC.: COMPANY OVERVIEW
  • TABLE 287 ATRICURE, INC.: PRODUCTS OFFERED
  • TABLE 288 ATRICURE, INC.: PRODUCT APPROVALS/ LAUNCHES
  • TABLE 289 MICREL MEDICAL DEVICES SA: COMPANY OVERVIEW
  • TABLE 290 MICREL MEDICAL DEVICES SA: PRODUCTS OFFERED
  • TABLE 291 ZYNEX, INC.: COMPANY OVERVIEW
  • TABLE 292 ZYNEX, INC: PRODUCTS OFFERED
  • TABLE 293 ENOVIS CORPORATION: COMPANY OVERVIEW
  • TABLE 294 ENOVIS CORPORATION: PRODUCTS OFFERED

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC
  • FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 5 TOP-DOWN APPROACH
  • FIGURE 6 DATA TRIANGULATION
  • FIGURE 7 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 8 NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 INFUSION PUMPS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 ABLATION DEVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 PAIN MANAGEMENT DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 PAIN MANAGEMENT DEVICES MARKET, BY REGION
  • FIGURE 15 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG GERIATRIC POPULATION TO DRIVE MARKET
  • FIGURE 16 NEUROPATHIC PAIN AND CHINA TO BE MAJOR STAKEHOLDERS IN 2023
  • FIGURE 17 CHINA TO FASTEST-GROWING MARKET FOR PAIN MANAGEMENT DEVICES DURING FORECAST PERIOD
  • FIGURE 18 PAIN MANAGEMENT DEVICES MARKET DYNAMICS
  • FIGURE 19 SUPPLY CHAIN ANALYSIS
  • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 21 PRE-MARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 24 LATIN AMERICA: REGULATORY SCENARIO
  • FIGURE 25 BRAZIL: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 26 MEXICO: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 27 PATENT ANALYSIS, 2014-2024
  • FIGURE 28 GLOBAL PATENT APPLICATIONS, 2014-2024
  • FIGURE 29 INDICATIVE PRICING OF PAIN MANAGEMENT DEVICES, BY TYPE, 2023 (USD)
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TYPE
  • FIGURE 31 KEY BUYING CRITERIA, BY TYPE
  • FIGURE 32 ECOSYSTEM ANALYSIS
  • FIGURE 33 VALUE CHAIN ANALYSIS
  • FIGURE 34 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 35 INVESTMENT AND FUNDING SCENARIO, 2019-2023
  • FIGURE 36 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
  • FIGURE 38 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
  • FIGURE 39 REVENUE ANALYSIS OF TOP THREE PLAYERS, 2021-2023
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 41 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 42 COMPANY FOOTPRINT
  • FIGURE 43 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 44 BRAND/PRODUCT COMPARISON
  • FIGURE 45 R&D EXPENDITURE OF KEY PLAYERS, 2021-2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 51 NEVRO CORP.: COMPANY SNAPSHOT
  • FIGURE 52 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 53 STRYKER: COMPANY SNAPSHOT
  • FIGURE 54 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 55 BAXTER: COMPANY SNAPSHOT
  • FIGURE 56 OMRON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 57 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 58 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 59 ICU MEDICAL: COMPANY SNAPSHOT
  • FIGURE 60 NIPRO: COMPANY SNAPSHOT
  • FIGURE 61 MOOG INC.: COMPANY SNAPSHOT
  • FIGURE 62 ATRICURE, INC.: COMPANY SNAPSHOT
  • FIGURE 63 ZYNEX, INC.: COMPANY SNAPSHOT
  • FIGURE 64 ENOVIS CORPORATION: COMPANY SNAPSHOT